This page was translated automatically from Turkish. Read the original

This page is an AI-assisted Turkish summary of the study presented at the 26th World Congress of Psychiatry. The study belongs to the presenting authors; please refer to the original source when citing it.

EV1015

A living map of international psychiatric treatment guidelines to support the adoption and adaptation of recommendations in guideline development

LIVING MAP OF INTERNATIONAL PSYCHIATRIC TREATMENT GUIDELINES TO SUPPORT ADOPTION AND ADAPTION IN GUIDELINE DEVELOPMENT

A continuously updated map of international psychiatric guidelines provides a resource for adopting or adapting recommendations when developing new national guidelines.

The aim is to create a living map that can inform the development of new evidence-based recommendations by systematically collecting and evaluating psychiatric treatment guidelines produced by different countries and organizations. The methods involved searching published international clinical guidelines covering various psychiatric disorders; two independent reviewers assessed the quality of each guideline’s development process and the scientific evidence supporting its recommendations using Domain 3 (Rigour of Development) of the AGREE II instrument. In addition, a third independent assessment was conducted using specially designed ChatGPT-based prompts; guidelines were classified as low (below 40%), moderate (40%–69%), or high (70% and above) quality based on the mean total scores from the AGREE II signalling questions across the three assessments. The map presented in the poster displays guidelines by publication year (2016 to 2026) and condition under the categories of bipolar disorder, depression, personality disorders, schizophrenia and other psychotic disorders, suicide, sleep disorders, and anxiety, with individual guidelines potentially appearing in more than one location. The assessment identified numerous moderate- and high-quality guidelines, including guidelines on depression, anxiety disorders, bipolar disorder, schizophrenia, insomnia, suicide, and perinatal mental health published between 2023 and 2025 from the Netherlands, the United States, Canada, Australia, and Japan; methodological approaches and transparency were reported to vary, many guidelines combined evidence-based and consensus-based recommendations, and certainty of evidence was frequently assessed using the GRADE approach and the GRADE Evidence to Decision (EtD) framework. In conclusion, the GRADE adolopment approach allows existing recommendations to be adopted and adapted, with de novo recommendation development required only for questions not adequately addressed by current evidence. This approach enables efficient use of resources, reduces duplication of effort across organizations, and is being used to develop Sweden’s new national psychiatric guidelines, scheduled for publication in 2028.

All WCP 2026 summaries